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Background
Controlled Clinical Trials are the Gold Standard to assess
the efficacy and safety of a new therapeutic intervention.
Furthermore, their results are used to make decisions in
relation to public health issues[1]. This study describes
the experience of the National Centre of Clinical Trials
(CENCEC) of Cuba[2] introducing research results into
medical practice, extending new therapeutic technologies,
identifying barriers to the translation of research into
medical practice, improving the evidence for making
decisions in public health and improving the delivery of
medical services[3].
Material and methods
All trials led by CENCEC from 1992 to 2013 were char-
acterized according to specific variables. A review of
available information at the Cuban Regulatory Agency
regarding the registration process of new drugs was per-
formed. Interviews to sponsors, clinical investigators and
health authorities were carried out to identify products
registered outside the country, health benefits and
impact of the results of clinical trials conducted by
CENCEC.
Results
In this period, 133 clinical trials were completed evaluat-
ing 58 products from 28 sponsors, with participation of
1075 clinical sites from 90 hospitals and 60 primary care
health care units involving 4241 researchers. Some of
those studies were performed for the evaluation of health
technologies and to search evidence for public health
decisions. The activities of CENCEC were carried out
according to international standards: Quality Assurance
System Certificated (ISO 9001:2008), Cuban Public Reg-
istry of Clinical Trials (WHO Primary registry [4] and
role as regional coordinator of Good Clinical Practices
Working Group (PANDRHA) among others.
The benefits of “new intervention” clinical trials were
related to morbidity and mortality rates, new patterns of
disease management, better Infrastructure of clinical
sites, improvement of the quality of medical care, the
introduction of new technologies and the building of
capacity of clinical investigators [5].
Conclusions
The experience of Cuba, a low income country with a
defined health policy, shows that the results of clinical
trials are an effective tool to improve health services and
for an efficient introduction of evidence in medical prac-
tice, for decision making in public health leading to
improvements in clinical care. The experience gained
could be applied in other countries of Latin America to
achieve public health results .
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